Papers

334 results
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System category M: a systematic review and meta-analysis.
Shin J, Lee S, Kim YY, Chung YE, Choi JY, Park MS - Ultrasonography (Seoul, Korea), July 23, 2021 2 citations
P
Hepatocellular carcinomas (HCCs), non-HCC malignancies
I/C
Contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System category M (LR-M), CEUS LR-M category, Non-HCC malignancies
O
Proportion of CEUS LR-M in HCC and non-HCC malignancies, Frequency of individual CEUS LR-M imaging features
P
I/C
l, o, w, -, l, e, v, e, l, , a, r, s, e, n, i, c, , (, A, s, ), , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r, d, r, i, n, k, i, n, g, , w, a, t, e, r, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, s, , l, o, w, e, r, , t, h, a, n, , t, h, e, , W, H, O, , p, r, o, v, i, s, i, o, n, a, l, , g, u, i, d, e, l, i, n, e, , v, a, l, u, e, , (, 1, 0, , µ, g, /, L, )
O
p, o, o, l, e, d, , a, s, s, o, c, i, a, t, i, o, n, , b, e, t, w, e, e, n, , t, h, e, , r, e, l, a, t, i, v, e, , r, i, s, k, , o, f, , e, a, c, h, , c, a, r, d, i, o, v, a, s, c, u, l, a, r, , d, i, s, e, a, s, e, , (, C, V, D, ), , e, n, d, p, o, i, n, t, , a, n, d, , l, o, w, -, l, e, v, e, l, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r
Liver imaging reporting and data system category M: A systematic review and meta-analysis.
Kim DH, Choi SH, Park SH, Kim KW, Byun JH, Kim SY, Lee SS, Shin YM, Won HJ, Kim PN - Liver international : official journal of the International Association for the Study of the Liver, March 05, 2020 20 citations
P
patients with liver lesions
I/C
LI-RADS algorithm, original studies reporting probability of LR-M for HCC and non-HCC malignancy on MRI
O
pooled percentages of HCC and non-HCC malignancy for LR-M, sources of heterogeneity between reported results
Health professionals' attitudes toward religiosity and spirituality: a NERSH Data Pool based on 23 surveys from six continents.
Kørup A, Søndergaard J, Alyousefi NA, Lucchetti G, Baumann K, Lee E, Karimah A, Ramakrishnan P, Frick E, Büssing A, Schouten E, Butcher W, Hefti R, Wermuth I, de Diego-Cordero R, Menegatti-Chequini MC, Hvidt NC - F1000Research, December 08, 2021 3 citations
P
health professionals (HPs)
I/C
formal R/S-training, physicians, nurses
O
belief in influence of R/S on patients' health, prevalence of formal R/S-training
P
metastatic or recurrent gastric cancer patients
I/C
capecitabine-based chemotherapy, S-1-based chemotherapy
O
objective response rate, 6-, 12-, and 18-month progression-free survival, 1-, 2-, and 3-year overall survival, adverse events (hand-foot syndrome, neutropenia)
Carotid artery revascularization using second generation stents versus surgery: a meta-analysis of clinical outcomes.
Mazurek A, Malinowski K, Sirignano P, Kolvenbach R, Capoccia L, DE Donato G, VAN Herzeele I, Siddiqui AH, Castrucci T, Tekieli L, Stefanini M, Wissgott C, Rosenfield K, Metzger DC, Snyder K, Karpenko A, Kuczmik W, Stabile E, Knapik M, Casana R, Pieniazek P, Podlasek A, Taurino M, Schofer J, Cremonesi A, Sievert H, Schmidt A, Grunwald IQ, Speziale F, Setacci C, Musialek P, null null - The Journal of cardiovascular surgery, February 22, 2024 3 citations
P
Casper/Roadsaver, CGuard, Gore stent
I/C
second-generation ('mesh') carotid stents (SGS), carotid endarterectomy (CEA)
O
30-day death (D), stroke (S), myocardial infarction (M), 12-month ipsilateral stroke and restenosis
Investigation of S-Nitrosoglutathione in stroke: A systematic review and meta-analysis of literature in pre-clinical and clinical research.
Liu S, Zheng H, Yu W, Ramakrishnan V, Shah S, Gonzalez LF, Singh I, Graffagnino C, Feng W - Experimental neurology, March 03, 2020 6 citations
P
GSNO
I/C
S-Nitrosoglutathione, Placebo
O
Infarct size, Neurological behavior scales, Embolic signals
5-HTTLPR polymorphism and depression risk in Parkinson's disease: an updated meta-analysis.
Cheng P, Zhang J, Wu Y, Liu W, Zhu J, Chen Z, Zhang J, Guan S, Sun Y, Wang J - Acta neurologica Belgica, March 29, 2020 7 citations
P
PD patients
I/C
5-HTTLPR genotype (S/S-Allele), PD patients without depression
O
Depression risk
Echocardiographic systolic pulmonary arterial pressure and mortality in coronavirus disease 2019 patients.
Zuin M, Roncon L, Zuliani G - Journal of cardiovascular medicine (Hagerstown, Md.), January 12, 2022 2 citations
P
COVID-19 survivors (S), nonsurvivors (NS)
I/C
echocardiographic systolic pulmonary arterial pressure (sPAP) measurement, sPAP difference between nonsurvivors and survivors
O
11.8mmHg (95% CI, 6.60-16.97; P < 0.0001, I2 = 89.3%) higher in NS compared with S
P
316 patients
I/C
S-1/cisplatin (SP), other combination chemotherapy, SP arm, non-SP arm
O
overall survival (OS), progression-free survival (PFS), objective response rate (ORR), toxicities, treatment delivery
CEO: Hwi-yeol YunCOO: Jung-woo ChaeCTO: Sangkeun Jung
Location: 204, W6, Chungnam National University, 99, Daehak-ro, Yuseong-gu, Daejeon, Republic of Korea
Tel: 042-821-7328E-mail: webmaster@lilac-co.kr
Copyright © 2024 by LiLac. All Rights Reserved.